Genocea names Katrine Bosley as chairman; EU defends plan to handle Syrian polio threat;

> Genocea Biosciences has named Katrine Bosley as chairman of its board of directors. News

> The European Centre for Disease Prevention and Control has responded to concerns about its handling of the Syrian polio threat. Letter

> Experts have warned that the U.S. lacks the surge capacity to handle a pandemic. Feature

> Roche ($RHHBY) has strengthened its cancer vaccine pipeline through a deal with immatics. Article

> Bavarian Nordic has completed its delivery of 20 million smallpox vaccines to the U.S. stockpile. Item

> The resurgence of the Welsh measles outbreak has prompted fresh calls for a vaccination campaign. Piece

> A nurse who described an unvaccinated child as a 'loser' has kept her job. News

> The opening of South Africa-based Litha Healthcare's vaccine plant is being held up by regulatory red tape. Article

> Inovio Pharmaceuticals ($INO) has presented positive preclinical data on its MERS-CoV vaccine. Item

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.